Feasibility and preliminary efficacy of the Balance Program to reduce pain‐related disability in pediatric sickle cell disease
Pediatric Blood & Cancer · 2023
DOI: 10.1002/pbc.30667 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Megan E Connolly und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics and Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, Di…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Pain Management, Pain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIH National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Background
Sickle cell disease (SCD) pain is associated with functional impairment, and treatment is often limited to pharmacological approaches with unwanted side effects. Although behavioral interventions exist for non‐SCD pain populations, interventions designed to address pain‐related impairment in SCD are lacking.
Methods
Twenty youth (9‐17 years) with SCD completed a four‐week telemedicine pain intervention (NCT04388241). Participants and caregivers completed baseline and post‐intervention PROMIS pain measures and the Treatment Evaluation Inventory‐Short Form (TEI‐SF). Descriptive analyses assessed feasibility and acceptability. Reliable Change Index analyses assessed for significant post‐intervention changes in pain functioning. Paired t test analyses compared baseline and post‐intervention opioid prescription fills.
Results
All participants completed at least one treatment session. Eighteen (90%) youth completed all sessions. Youth (100%) and caregivers (94%) rated the intervention as moderately or highly acceptable on the TEI‐SF. Forty‐seven percent of caregivers and 44% of youth reported reliably significant improvements in pain interference after the intervention (median T‐score differences: 24.8 and 23.5, respectively). Sixty‐five percent of caregivers (T‐score improvement difference: 19.3) and 31% of youth (T‐score improvement difference: 32) reported improvements in pain behaviors. There was no significant difference in opioid prescription fills pre‐ and post‐intervention ( P > 0.05).
Conclusions
The Balance Program is feasible, highly acceptable, and can be delivered remotely to reduce barriers to care. Approximately half of youth and caregivers reported significant declines in pain interference following the intervention, with substantial improvements in functioning for treatment responders. Behavioral pain interventions are important adjunctive treatments to uniquely address functional impairment associated with acute and chronic pain in SCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Pediatrics and Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
- Divisions of Hematology and Oncology, Children's National Hospital, Washington, District of Columbia, USA.
- Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
ORCID-Profile: Megan E Connolly, Christina M Sharkey, Deepika S Darbari, Steven J Hardy
Förderung
- NCATS NIH HHS
- NIH National Center for Advancing Translational Sciences
Zitieren
APA
Connolly, M. E., Forman, S., Sharkey, C. M., Merwin, S., Darbari, D. S., & Hardy, S. J. (2023). Feasibility and preliminary efficacy of the Balance Program to reduce pain‐related disability in pediatric sickle cell disease. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30667
Vancouver
Connolly ME, Forman S, Sharkey CM, Merwin S, Darbari DS, Hardy SJ. Feasibility and preliminary efficacy of the Balance Program to reduce pain‐related disability in pediatric sickle cell disease. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30667
BibTeX
@article{Connolly2023,
author = {Connolly, Megan E and Forman, Sydney and Sharkey, Christina M and Merwin, Stephanie and Darbari, Deepika S and Hardy, Steven J},
title = {Feasibility and preliminary efficacy of the Balance Program to reduce pain‐related disability in pediatric sickle cell disease},
journal = {Pediatric Blood & Cancer},
year = {2023},
doi = {10.1002/pbc.30667}
}
EUVIMED